FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2318513585> ?p ?o ?g. }

• W2318513585 abstract "Background Anti-TNF-α are effectively used in management of AS, a chronic disease with increased risk of future cardiovascular events, but influence and additional benefit of these agents on arterial stiffness, a potentially modifiable risk marker for cardiovascular events, is controversial. Objectives Our aim was to evaluate the long term effectiveness on arterial stiffness [pulse wave velocity (PVW)] treated anti-TNF alpha treatment in AS. Our initial follow-up (24 week) study on the effectiveness of anti-TNF-α therapy on arterial stiffness in AS did not demonstrate any clear benefit, and since optimal follow-up period for observing this effect remains unknown we aimed to document further follow-up of these patients at 2 years. Methods A total 28 active AS patients (21 male, 7 female) were enrolled before initiation of biological therapy and their mid-term (24 weeks) evaluation was reported. For further evaluation initially reported patients were contacted 2 years after anti-TNF-α therapy, and arterial stiffness was assessed by using PWV Results After 2 year of anti-TNF-α therapy, despite significant improvements in patients’ symptoms and clinical activity parameters including BASDAI score, erythrocyte sedimentation rate and C-reactive protein (p=0.001, p=0.015, p=0.001, respectively) no significant change was obtained in arterial stiffness parameters (7.9 ± 1.3 meter/second, 7.7 ± 1.3 meter/second and 8.3 ±1.1 meter/second, p=0.620). Conclusions In parallel with the previous 24-week evaluation, results at 2-year follow-up time point indicates that anti-TNF-α therapy does not improve arterial stiffness in patients with AS. References Arnett FC. Ankylosing Spondylitis. In: Koopman WJ, ed. Arthritis and Allied Condition. Philadelphia: Lippincott Williams and Wilkins, 2001:1317. Karkucak M, Cakirbay H, Capkin E, Topbas M, Guler M, Tosun M, et al. The prevalance of ankylosing spondylitis in the eastern Black Sea region of Turkey. Eur J Gen Med 2011;8 (1):40-5. Capkin E, Kiris A, Karkucak M, Durmus I, Gokmen F, Cansu A, et al. Investigation of effects of different treatment modalities on structural and functional vessel wall properties in patients with ankylosing spondylitis. Joint Bone Spine 2011;78(4):378-82. Capkin E, Karkucak M, Kiris A, Durmus I, Karaman K, Karaca Aet al. Anti-TNF Alpha therapy may not improve arterial stiffnes in patients with ankylosing spondylitis: 24 weeks-follow up. Rheumatology (oxford) 2012; 51(5):910-4. Disclosure of Interest None Declared" @default.
• W2318513585 created "2016-06-24" @default.
• W2318513585 creator A5005880826 @default.
• W2318513585 creator A5016665857 @default.
• W2318513585 creator A5017106566 @default.
• W2318513585 creator A5035817129 @default.
• W2318513585 creator A5040776819 @default.
• W2318513585 creator A5044320853 @default.
• W2318513585 creator A5044528928 @default.
• W2318513585 creator A5059604519 @default.
• W2318513585 date "2013-06-01" @default.
• W2318513585 modified "2023-09-26" @default.
• W2318513585 title "FRI0428 Anti –tnf-a therapy and arterial stiffness in anklosing spondylitis; results with long-term 2 year- follow-up" @default.
• W2318513585 doi "https://doi.org/10.1136/annrheumdis-2013-eular.1555" @default.
• W2318513585 hasPublicationYear "2013" @default.
• W2318513585 type Work @default.
• W2318513585 sameAs 2318513585 @default.
• W2318513585 citedByCount "0" @default.
• W2318513585 crossrefType "journal-article" @default.
• W2318513585 hasAuthorship W2318513585A5005880826 @default.
• W2318513585 hasAuthorship W2318513585A5016665857 @default.
• W2318513585 hasAuthorship W2318513585A5017106566 @default.
• W2318513585 hasAuthorship W2318513585A5035817129 @default.
• W2318513585 hasAuthorship W2318513585A5040776819 @default.
• W2318513585 hasAuthorship W2318513585A5044320853 @default.
• W2318513585 hasAuthorship W2318513585A5044528928 @default.
• W2318513585 hasAuthorship W2318513585A5059604519 @default.
• W2318513585 hasConcept C126322002 @default.
• W2318513585 hasConcept C141071460 @default.
• W2318513585 hasConcept C164705383 @default.
• W2318513585 hasConcept C1862650 @default.
• W2318513585 hasConcept C2775850156 @default.
• W2318513585 hasConcept C2776260265 @default.
• W2318513585 hasConcept C2777402515 @default.
• W2318513585 hasConcept C2777453003 @default.
• W2318513585 hasConcept C2778143017 @default.
• W2318513585 hasConcept C2778319312 @default.
• W2318513585 hasConcept C2779134260 @default.
• W2318513585 hasConcept C2779650986 @default.
• W2318513585 hasConcept C71924100 @default.
• W2318513585 hasConcept C84393581 @default.
• W2318513585 hasConceptScore W2318513585C126322002 @default.
• W2318513585 hasConceptScore W2318513585C141071460 @default.
• W2318513585 hasConceptScore W2318513585C164705383 @default.
• W2318513585 hasConceptScore W2318513585C1862650 @default.
• W2318513585 hasConceptScore W2318513585C2775850156 @default.
• W2318513585 hasConceptScore W2318513585C2776260265 @default.
• W2318513585 hasConceptScore W2318513585C2777402515 @default.
• W2318513585 hasConceptScore W2318513585C2777453003 @default.
• W2318513585 hasConceptScore W2318513585C2778143017 @default.
• W2318513585 hasConceptScore W2318513585C2778319312 @default.
• W2318513585 hasConceptScore W2318513585C2779134260 @default.
• W2318513585 hasConceptScore W2318513585C2779650986 @default.
• W2318513585 hasConceptScore W2318513585C71924100 @default.
• W2318513585 hasConceptScore W2318513585C84393581 @default.
• W2318513585 hasLocation W23185135851 @default.
• W2318513585 hasOpenAccess W2318513585 @default.
• W2318513585 hasPrimaryLocation W23185135851 @default.
• W2318513585 isParatext "false" @default.
• W2318513585 isRetracted "false" @default.
• W2318513585 magId "2318513585" @default.
• W2318513585 workType "article" @default.